SWS Medical(SH:688410) Xin Lang Zheng Quan·2025-10-13 01:26Core Insights - On October 10, the stock of Chongqing Shanwaishan Blood Purification Technology Co., Ltd. increased by 3.66%, with a trading volume of 134 million yuan [1] - As of October 10, the company had a total margin balance of 113 million yuan, with a net margin purchase of 1.69 million yuan on that day [1][2] - For the first half of 2025, the company reported a revenue of 357 million yuan, representing a year-on-year growth of 28.72%, and a net profit of 55 million yuan, up 20.28% year-on-year [2] Financing and Margin Data - On October 10, the financing buy amount was 10.93 million yuan, with a current financing balance of 113 million yuan, accounting for 3.08% of the circulating market value [1] - The financing balance is above the 80th percentile level over the past year, indicating a high level of financing activity [1] - The company had no short selling activity on October 10, with a short selling balance of 0.00 yuan, which is below the 30th percentile level over the past year, indicating low short selling interest [1] Shareholder and Dividend Information - As of June 30, the number of shareholders increased by 2.67% to 8,150, while the average circulating shares per person decreased by 2.60% to 28,779 shares [2] - Since its A-share listing, the company has distributed a total of 104 million yuan in dividends [3] - Among the top ten circulating shareholders, Bosera Healthcare Mixed A (050026) is the fifth largest shareholder, increasing its holdings by 746,300 shares [3]